Edition:
United States

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

3.14USD
8 Dec 2017
Change (% chg)

$0.06 (+1.95%)
Prev Close
$3.08
Open
$3.06
Day's High
$3.14
Day's Low
$3.05
Volume
2,966
Avg. Vol
13,142
52-wk High
$5.25
52-wk Low
$2.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
FY 2015 Dec '15 0.00 -0.069
Sep '15 0.00 -0.522
Jun '15 0.00 -0.228
Mar '15 0.00 -0.124
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 1 -0.23 -0.23 -0.23 -0.11
Quarter Ending Mar-18 1 -0.17 -0.17 -0.17 --
Year Ending Dec-17 1 -1.06 -1.06 -1.06 -0.48
Year Ending Dec-18 1 -0.79 -0.79 -0.79 -0.46
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.13 35.51
P/E High - Last 5 Yrs. -- 40.67 45.27
P/E Low - Last 5 Yrs. -- 23.64 24.24
Beta -- 0.92 0.91
Price to Sales (TTM) -- 3.92 5.83
Price to Book (MRQ) 12.79 4.88 5.68
Price to Tangible Book (MRQ) -- 5.74 7.26
Price to Cash Flow (TTM) -- 23.07 24.44
% Owned Institutions 8.09 0.85 1.39

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.28 5.23
Payout Ratio(TTM) -- 47.28 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 5.18 5.65
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.45 7.15 7.23
EPS (TTM) vs TTM 1 Yr. Ago -20.55 -- --
EPS - 5 Yr. Growth Rate -- 9.89 10.90
Capital Spending - 5 Yr. Growth Rate -- 15.17 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.54
Current Ratio (MRQ) 1.17 3.51 3.56
LT Debt to Equity (MRQ) 0.00 10.90 13.23
Total Debt to Equity (MRQ) 12.02 17.04 19.24
Interest Coverage (TTM) -1.40 49.98 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.80
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.39 15.52
Operating Margin (TTM) -- 14.77 6.76
Operating Margin - 5 Yr. Avg. -- 14.38 11.03
Pre-Tax Margin (TTM) -- 15.22 7.58
Pre-Tax Margin - 5 Yr. Avg. -- 14.69 11.44
Net Profit Margin (TTM) -- 11.39 3.81
Net Profit Margin - 5 Yr. Avg. -- 11.02 7.73
Effective Tax Rate (TTM) -- 24.35 24.25
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 952,857,028 858,823,705
Net Income/Employee (TTM) -- 111,290,090 100,224,560
Receivable Turnover (TTM) -- 5.92 6.12
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.00 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -229.38 11.89 11.35
Return on Assets - 5 Yr. Avg. -- 12.90 12.32
Return on Investment (TTM) -- 15.10 14.47
Return on Investment - 5 Yr. Avg. -- 16.88 16.13
Return on Equity (TTM) -- 16.59 16.06
Return on Equity - 5 Yr. Avg. -- 17.87 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -264.31 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.09%
# of Holders: 18
Total Shares Held: 935,084
3 Mo. Net Change: 309,346
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 3
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.